NOG anticorps
-
- Antigène Voir toutes NOG Anticorps
- NOG (Noggin (NOG))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NOG est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Synthetic peptide of human NOG
- Isotype
- IgG
- Top Product
- Discover our top product NOG Anticorps primaire
-
-
- Indications d'application
- IHC 1:25-1:100, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.9 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- NOG (Noggin (NOG))
- Autre désignation
- NOG (NOG Produits)
- Synonymes
- anticorps SYM1, anticorps SYNS1, anticorps nog-A, anticorps nog1, anticorps noggin-1, anticorps noggin, anticorps noggin, anticorps noggin L homeolog, anticorps noggin protein, anticorps NOG, anticorps Nog, anticorps nog.L, anticorps noggin
- Sujet
- NOG (Noggin) is a Protein Coding gene. Diseases associated with NOG include Tarsal-Carpal Coalition Syndrome and Brachydactyly, Type B2. Among its related pathways are Mesodermal Commitment Pathway and Differentiation Pathway. GO annotations related to this gene include protein homodimerization activity and cytokine binding.The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified, both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene.
- UniProt
- Q13253
- Pathways
- Stem Cell Maintenance, Tube Formation
-